WO2017073826A1 - Super absorbent zero gel dressing for treating wound - Google Patents

Super absorbent zero gel dressing for treating wound Download PDF

Info

Publication number
WO2017073826A1
WO2017073826A1 PCT/KR2015/011600 KR2015011600W WO2017073826A1 WO 2017073826 A1 WO2017073826 A1 WO 2017073826A1 KR 2015011600 W KR2015011600 W KR 2015011600W WO 2017073826 A1 WO2017073826 A1 WO 2017073826A1
Authority
WO
WIPO (PCT)
Prior art keywords
zero gel
weight
zero
wound
gel
Prior art date
Application number
PCT/KR2015/011600
Other languages
French (fr)
Korean (ko)
Inventor
이태완
Original Assignee
이태완
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이태완 filed Critical 이태완
Publication of WO2017073826A1 publication Critical patent/WO2017073826A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents

Definitions

  • the present invention relates to a super absorbent zero gel dressing agent for wound treatment, and more particularly, to a super absorbent zero gel dressing agent for wound treatment having a thin thickness, high absorption, and low adhesion.
  • Skin which has the largest surface area in the human body, is an organ that plays an important role in protecting the body from harmful environmental conditions such as ultraviolet rays, biochemicals, etc., and controlling water vaporization and body temperature in the body.
  • skin damage such as burns, trauma, wounds, bedsores, etc. occur frequently in daily life, and if left undamaged skin can cause severe defects through secondary contamination, the wound must be quickly treated to remove various side effects.
  • the wounds When treating wounds in a dry environment such as disinfectants or gauze, the wounds are treated later because the components that heal the wounds with the disinfectant lose their activity, or they dry out by evaporation of water, causing cells to die and delay cell growth. In most cases, scarring was caused by scabs.
  • the gauze is attached to the wound to give a trauma to the wound when replacing the dressing, there is a problem causing pain when peeling off.
  • the wet dressing agent blocks bacteria or foreign substances from the outside, activates the cell regeneration component through the exudates so that the skin regeneration epithelial cells can grow smoothly by creating a wet environment around the wound, and no scab is formed. It is effective in healing wounds quickly without scars.
  • Korean Patent Laid-Open No. 10-2015-00063223 discloses a method of preparing a hydrogel by mixing cationic materials such as chitosan and anionic materials such as carboxymethyl cellulose with electrostatic attraction. Although excellent injectable drug carriers are characterized, there is a big disadvantage of crosslinking by mixing the cationic material and anionic material in a solution state for 30 to 50 hours.
  • Korean Patent Publication No. 10-2014-0016450 discloses an aqueous solution of keratin derivatives by dissolving keratin derivatives extracted from the hair of animals including humans in water to prepare hydrogels having excellent biocompatibility. After adding and dissolving polyethyleneimine to prepare a mixture aqueous solution, a method of preparing a hydrogel useful for wound healing or skin regeneration by irradiating the mixture aqueous solution with radiation is disclosed. This has the advantage of being eco-friendly and biocompatible because it can produce hydrogels with minimal chemicals.However, it can be easily discolored or discolored by the production of low-molecular weight by-products for wound treatment or skin regeneration. Use as a hydrogel has an unsuitable problem.
  • Korean Patent No. 20-0390463 discloses a method for preparing a wound band by applying a hydrogel composed of glycerin, polyethylene glycol, purified water, sodium polyacrylate, tartaric acid, and dry aluminum hydroxide to a nonwoven fabric.
  • a hydrogel composed of glycerin, polyethylene glycol, purified water, sodium polyacrylate, tartaric acid, and dry aluminum hydroxide.
  • the present inventors have made diligent efforts to solve the above problems, and when the content of purified water, water-soluble polymer, crosslinking agent and plasticizer is properly adjusted, the thickness of thin, high absorbency, and low adhesion, super absorbent zero gel dressing for wound treatment It was confirmed that the agent can be produced, and the present invention was completed.
  • An object of the present invention is to provide a zero gel dressing agent having a thin thickness, high water absorption, and low adhesion.
  • the present invention (a) a support; (b) a zero gel stacked on top of the support; (c) an adhesive cloth laminated on the lower portion of the support; And (d) a zero gel dressing agent comprising a release film coated on the zero gel, wherein the zero gel is 10 to 40% by weight of purified water; Plasticizer 45-80 wt%; It provides a zero gel dressing agent comprising 8 to 13% by weight of a water-soluble polymer and 0.01 to 5% by weight of a crosslinking agent.
  • the plasticizer is at least one member selected from the group consisting of glycerin, 1,3-butylene glycol, propylene glycol, sorbitol, dipropylene glycol, ethylene glycol and polyethylene glycol.
  • the water-soluble polymer is characterized in that at least one member selected from the group consisting of natural polymers, synthetic polymers and semi-synthetic polymers.
  • the crosslinking agent is at least one member selected from the group consisting of aluminum hydroxide, aluminum magnesium silicate, aluminum glycinate, aluminum chloride and aluminum sulfate.
  • the thickness of the zero gel is 100 ⁇ 300 ⁇ m
  • the adhesive strength of the zero gel according to the measurement method is less than No. 5 (diameter: 9.5mm, weight: 3.5g) of the iron beads
  • the absorbency is It is characterized by more than 400%.
  • Zero-gel is cut into 10cm ⁇ 10cm size and the sample adhesive face up on the inclined surface by using the adhesion tester with the inclination angle of 30 ° and the length of 30cm on the inclined surface. Measure the lake of the bead when it rolls from the upper end of the slope along the lake of the iron ball.
  • the gel was cut into 5cm ⁇ 5cm size and immersed in 25 °C physiological saline solution (0.9% sodium chloride solution) for 1 hour, then taken out and dried at room temperature for 10 minutes, and the weight change was measured and calculated by the following equation.
  • the zero gel of the dressing agent according to the present invention is a cross-linked body of a three-dimensional network structure, which has a low water content, thereby improving the absorption function of the effusion solution, the wound healing effect is very fast, the adhesive strength is very low, and the thickness is small so that it does not stick to the wound.
  • you remove it there is little pain, no residue is left, and a large amount of plasticizer creates a moisturizing environment, so the wound is smoothly treated, and there is no scab, so there is almost no scar after treatment.
  • FIG. 1 is a photograph of a zero gel dressing agent prepared according to an embodiment of the present invention.
  • the plasticizer is a composition that is correlated with the content of purified water, and when the content of the purified water is low, the content of the plasticizer should be increased, and glycerin, 1,3-butylene glycol, propylene glycol, sorbitol, dipropylene glycol, It can be used 1 type or in mixture of 2 or more types from ethylene glycol and polyethylene glycol, and it is preferable to use 45-80 weight%.
  • the content of the plasticizer is less than 45% by weight, there is no flexibility, and when the content of the plasticizer exceeds 80% by weight, the viscosity becomes very sticky and the crosslinking time is long.
  • the water-soluble polymer may be a natural polymer, a synthetic polymer and a semi-synthetic polymer as one component composed of a cross-linked body of a three-dimensional network structure, and as a natural polymer, collagen, gelatin, xanthan gum, carrageenan, agar, alginic acid or salts thereof , Hyaluronic acid or salts thereof, pectin, starch and the like can be used, and synthetic polymers include polyacrylic acid or salts thereof, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene oxide, methyl vinyl ether maleic anhydride copolymer, isobutylene anhydride Maleic acid copolymer, butyl methacrylate acrylic acid copolymer, methoxy ethylene maleic anhydride copolymer, etc. may be used.
  • a semi-synthetic polymer one or more components selected from sodium carboxymethyl cellulose, soluble starch, and carboxymethyl starch
  • the content of the water-soluble polymer is preferably 8 to 13% by weight. When the content of the water-soluble polymer is less than 8% by weight, the absorbency may be lowered or may be dissolved in water. When the content of the water-soluble polymer is greater than 13% by weight, the viscosity is high, so that it is difficult to formulate and difficult to apply thinly.
  • the crosslinking agent may be used in an amount of 0.01 to 5 wt% by mixing one or two or more kinds of aluminum compounds such as aluminum hydroxide, aluminum magnesium silicate, aluminum glycinate, aluminum chloride and aluminum sulfate.
  • aluminum compounds such as aluminum hydroxide, aluminum magnesium silicate, aluminum glycinate, aluminum chloride and aluminum sulfate.
  • Acidity regulator in the present invention has a function to control the crosslinking rate, organic acids such as citric acid, lactic acid, tartaric acid, glycolic acid and organic base such as monoethanolamine, diethanolamine, triethanolamine, diisopropanolamine It can be used, the content is preferably 0.01 to 5% by weight.
  • the reaction rate modifier may be used by mixing one or two or more of ethylenediaminetetraacetic acid and salts thereof, sodium polyacrylate (molecular weight: 10,000 or less), phosphate, and the content is 0.01 to 5% by weight. desirable.
  • preservatives may be used one or two or more of methylparaben, propylparaben, phenoxyethanol, 1,2-hexanediol, 1,2-octanediol, chlorophenesin, etc., the content of each It is recommended to use it as a standard based on the content announced by the Ministry of Food and Drug Safety.
  • the zero gel may further contain a surfactant, stabilizer, dissolution aid, pigment.
  • Surfactants are for promoting transdermal absorption and maintaining the stability of the compositions, anionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants can be used, one or two or more of these Can be used mixed.
  • the stabilizer may be used antioxidants such as dibutyl hydroxy toluene, sodium pyrosulfite, butyl hydroxy anisole, ascorbic acid
  • the dissolution aid may be selected from animal and vegetable oils or derivatives thereof.
  • the dye may be exemplified by titanium oxide, zinc oxide, iron oxide, water-soluble dyes, pigments, etc., but is not limited thereto.
  • the zero gel of the present invention may use additives such as medicinal ingredients, excipients, inorganic fillers, viscosity modifiers and the like having a wound healing function in a range that does not change the physical and chemical properties of the zero gel in addition to the above components as necessary.
  • the adhesive cloth is used by attaching the support to the center to attach the zero gel to the skin, one or two kinds of nonwoven fabric, fiber, cotton, rayon, polyethylene film, polyurethane film or polyethylene phthalate film. It can be used that the adhesive was applied to one surface of the above-mentioned laminated, and it is preferable to cut and use so that the sum of both lengths may become 10-50 mm larger than the magnitude
  • the zero gel dressing agent of the present invention may include a release film or a release paper to protect the zero gel layer directly contacting the wound from external contamination
  • the release film may be a transparent or white opaque polyethylene phthalate, polyethylene, polypropylene
  • Examples of the polyvinyl chloride and polycarbonate films may be exemplified
  • the release paper may be exemplified by release of silicone, fluorine, or the like after the paper is coated with polyethylene.
  • a release film or a release paper in the range of 10-200 micrometers. Less than 10 ⁇ m is too thin to maintain the shape of the zero gel is easy to be damaged, there is a problem that is difficult to handle because it is too thick when it exceeds 200 ⁇ m.
  • the thickness (weight conversion) of the zero gel having excellent flexibility is preferably 100 to 300 ⁇ m. If the thickness is less than 100 ⁇ m, it may be difficult to stack on the support, and the problem may be low in absorbency.
  • the adhesive force of the zero gel is characterized in that the lake of iron ball is less than 5 (diameter: 9.5mm, weight: 3.5g).
  • the adhesive strength of zero gel is an element that can safely treat a wound without causing pain or secondary trauma during dressing change, and can measure initial adhesive force.
  • the adhesive strength of the zero gel is measured by cutting the zero gel into a size of 10 cm ⁇ 10 cm and using the adhesion tester having an inclination angle of 30 ° and an inclination surface length of 30 cm. After pasting the paper on the upper 10cm, the lower 15cm or less of the, can be measured by the lake of the marble to stop when rolled from the upper end of the slope according to the lake of the iron ball of Table 1 below.
  • the high cohesion of the lake of iron ball 5 or more can cause pain or secondary trauma during dressing change.
  • the absorbency of the zero gel is a measure of the absorption ability of the exudate having a wound healing function, the higher the absorption, the better the wound healing ability, preferably 400% or more. If it is less than 400%, initial wound treatment may be delayed, which produces a large amount of exudate.
  • Absorbance of the zero gel in the present invention is cut to a size of 5cm ⁇ 5cm zero gel immersed in 25 °C physiological saline (0.9% sodium chloride solution) for 1 hour, then taken out and dried at room temperature for 10 minutes, weighed The amount of change can be measured and calculated by the following equation.
  • Example 1-4 and Comparative example 1 to 3 Zero gel Dressing agent manufacturing
  • composition (unit weight%) of Table 2 a crosslinking agent, a reaction rate regulator, a preservative, and a water-soluble polymer were added to the plasticizer to be uniformly dispersed, and then uniformly mixed with purified water in which the acidity regulator was dissolved to prepare a gel.
  • a gel was applied to a support (a nonwoven fabric having an average weight of 16 g / m 2, a 20 ⁇ m thick polyethylene film) at a constant thickness, a release film (75 ⁇ m thick transparent polyethylene phthalate film) was attached, and dried and aged to prepare a zero gel. By cutting to a constant size to prepare a gel preparation.
  • the zero gel of the present invention has a characteristic that the viscosity increases with time, and there is a limit in accurately measuring the viscosity using a viscometer, the uniformity at the time of blending is observed and compared, and the results are shown in Table 3 below. Shown in
  • the zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 5 cm ⁇ 5 cm and patched to the skin of 10 subjects for 6 hours, and then the residue and stickiness were examined. The analysis was carried out on a 5-point scale, and the results are shown in Table 4.
  • the zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 5 cm ⁇ 5 cm, immersed in 25 ° C. saline (0.9% sodium chloride solution) for 1 hour, and then taken out. After drying at room temperature for minutes, the weight change was measured and calculated by the following equation, and the results are shown in Table 5.
  • the zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 10 cm ⁇ 10 cm, and the adhesive surface of the specimen was placed on the inclined surface using an adhesion tester having a 30 cm length of inclined angle of 30 °. Place the paper on the top 10cm and the bottom 15cm of the inclined surface facing up, and measure the lake of the marble which stops when rolling at the upper end of the slope according to the lake of the iron ball, the results are shown in Table 6. . For reference, the diameter and weight of the steel ball by lake are shown in Table 7.
  • the zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 10 cm ⁇ 10 cm to accurately measure the weight of each sample, and the weight of the zero gel itself except the weight of the release film and the support. was calculated. When the weight is 1g, the thickness of the zero gel is converted to the same as 100 ⁇ m, and the results are shown in Table 8.
  • Examples 1 to 4 Comparative Example 1 and Comparative Example 2 were excellent except for Comparative Example 3 in which the content of the purified water in the uniformity was low, and Comparative Example 1 having a high plasticizer content was Sticky and residues remained on the skin, and when absorbance was measured, the gel absorbing saline melted and ran down.
  • Comparative Example 2 having a high purified water content showed a relatively low water absorption.
  • Comparative Example 3 showed a high water absorption, which is considered to be a phenomenon in which the content of purified water was low and appeared to be thickly applied.
  • Comparative Example 3 there is no residue when the skin attached, there were many opinions that the feeling of use is bad because of the heterogeneity to the thickness.
  • Comparative Examples 1 to 3 were found to have high adhesion, which may cause pain and secondary trauma when attached to the wound.
  • the wound healing ability of the zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 was evaluated for 30 days in the micro pigs of 3 months of age.
  • temperature 24 ⁇ 2 °C, relative humidity 50 ⁇ 10%, ventilation frequency 10 ⁇ 15 times (Hepa filter), contrast cycle 12 hours / day, roughness 200 lux, noise 45db and ammonia 20ppm were managed.
  • the entire skin layer was cut out on the back of the micro pig in the size of 3 cm ⁇ 3 cm, and in M and Example 1, which were made of polyurethane foam of Company I as a control.
  • the prepared composition was cut to a size of 5 cm x 5 cm and attached to each wound site three by three, and a 7 cm x 7 cm adhesive cloth was attached thereon so as not to be peeled off.
  • Example 1 The composition prepared in Example 1 and the control group were exchanged every 3 days, and the wound healing ability was calculated by the following equation after measuring the size of the wound with a PET film, measuring the area of the wound with an area program, and as a result, Is shown in Table 9.
  • control group showed a similar level as in Example 1 at the initial stage of the effusion, but after 9 days of no effusion, the wound was dried and the wound was very rough. The wound healing rate was significantly decreased.
  • Example 1 the wound healing effect appeared relatively quickly even when the wound was dry, and no scab was formed on the wound, and the wound was smoothly treated. It does not produce scabs because it creates a proper moisturizing environment even in the dry state without exudates.
  • the zero gel dressing agent according to the present invention does not adhere to the wound, so there is almost no pain when peeling off, no residue is left, and a large amount of plasticizer creates a moisturizing environment, so that the wound is smoothly treated, and no scabs are formed to treat it. Since there is an effect that scars hardly appear afterwards, it can be widely used as a dressing agent.

Abstract

The present invention relates to a super absorbent Zero Gel dressing material for treating a wound, and more specifically to a super absorbent Zero Gel dressing material for treating a wound having high absorbency and low adhesiveness. The Zero Gel of Zero Gel dressing material according to the present invention comprises: 10-40 wt% purified water; 45-80 wt% plasticizer; 8-13 wt% water-soluble polymer; and 0.01-5 wt% cross-linking agent. The Zero Gel of dressing material according to the present invention, being a cross-linked body having a three-dimensional networked structure, has low water content and thus enhances the absorption of exudate, has fast wound treating effect and very low adhesiveness, is thin to not stick to the wound and thus causes almost no pain when pulled off, does not leave residual material, treats the wound area smoothly as a moist environment is created due to a large amount of plasticizers, and does not produce a scab and thus produces almost no scarring post-treatment.

Description

상처 치료용 고흡수성 제로겔 드레싱Super Absorbent Zero Gel Dressing for Wound Care
본 발명은 상처 치료용 고흡수성 제로겔 드레싱제에 관한 것으로, 더욱 상세하게는 두께가 얇고, 흡수도가 높으며, 점착력이 낮은 상처 치료용 고흡수성 제로겔 드레싱제에 관한 것이다.The present invention relates to a super absorbent zero gel dressing agent for wound treatment, and more particularly, to a super absorbent zero gel dressing agent for wound treatment having a thin thickness, high absorption, and low adhesion.
인체에서 가장 큰 표면적을 가지는 피부는 자외선, 생ㆍ화학물질 등의 외부의 유해한 환경으로부터 몸을 보호하고, 체내의 수분증발 및 체온을 조절하는 중요한 역할을 하는 기관이다. 그러나 일상생활에서 화상, 외상, 창상, 욕창 등의 피부 손상이 흔히 일어나고 있으며, 손상된 피부를 방치할 경우 이차적인 오염을 통하여 심한 결함을 남길 수 있기 때문에 상처를 신속하게 치료하여 각종 부작용을 없애야 한다.Skin, which has the largest surface area in the human body, is an organ that plays an important role in protecting the body from harmful environmental conditions such as ultraviolet rays, biochemicals, etc., and controlling water vaporization and body temperature in the body. However, skin damage such as burns, trauma, wounds, bedsores, etc. occur frequently in daily life, and if left undamaged skin can cause severe defects through secondary contamination, the wound must be quickly treated to remove various side effects.
1962년 영국의 윈터 박사가 상처를 공기 중에 노출시키는 것보다 피부에서 자연적으로 나오는 삼출액(진물)을 통해 상처를 보습해주면 상처가 더 빠르게 치유된다는 것을 발견하였는데, 삼출액에는 다핵백혈구, 대식세포, 단백질분해효소, 세포성장인자 등의 여러 가지 상처 치료에 이로운 성분들이 포함되어 있는 것으로 알려지고 있다. In 1962, Dr. Winter, England, found that moisturizing wounds through natural exudates (skin) from the skin rather than exposing the wounds to the air heals the wounds faster, including multinucleated white blood cells, macrophages, and proteolytic degradation. It is known to contain beneficial ingredients for various wound healing such as enzymes and cell growth factors.
소독약이나 거즈와 같은 건조한 환경에서 상처를 치료하는 경우, 소독약에 의해 상처를 치료하는 성분들이 활성을 잃어버리거나, 수분 증발로 건조하게 되어 세포가 괴사하거나 세포성장이 지연되기 때문에 오히려 상처가 늦게 치료되고, 딱지에 의한 흉터가 생성되는 경우가 많았다. 또한, 거즈는 상처에 달라붙어 드레싱 교체 시 상처에 외상을 주고, 떼어 낼 때 통증을 유발하는 문제점이 있다. When treating wounds in a dry environment such as disinfectants or gauze, the wounds are treated later because the components that heal the wounds with the disinfectant lose their activity, or they dry out by evaporation of water, causing cells to die and delay cell growth. In most cases, scarring was caused by scabs. In addition, the gauze is attached to the wound to give a trauma to the wound when replacing the dressing, there is a problem causing pain when peeling off.
반면, 습윤 드레싱제는 세균이나 이물질을 외부로부터 차단시키고, 상처 주위에 습윤 환경을 만들어 피부재생 상피세포가 원활하게 성장할 수 있도록 삼출액을 통하여 세포재생성분의 활성을 활발하게 해주고, 딱지가 생기지 않으며, 흉터 없이 빠르게 상처를 치료하는 효과가 있다.On the other hand, the wet dressing agent blocks bacteria or foreign substances from the outside, activates the cell regeneration component through the exudates so that the skin regeneration epithelial cells can grow smoothly by creating a wet environment around the wound, and no scab is formed. It is effective in healing wounds quickly without scars.
이와 같이 상처치료에 유용하게 습윤 환경을 만들어 주는 제형으로는 하이드로콜로이드, 폴리우레탄폼 및 하이드로겔을 기제로 사용하는 드레싱제들이 알려져 있다. As such formulations that make a wet environment useful for wound healing are known, dressing agents using hydrocolloids, polyurethane foams and hydrogels as bases.
대한민국공개특허 제10-2015-00063223호는 키토산 등의 양이온성 물질과 카르복시메틸셀룰로오즈 등의 음이온성 물질을 정전기적 인력으로 혼합시켜 하이드로겔을 제조하는 방법을 개시하고 있는데, 세포와의 생체적합성이 우수하여 주사가 가능한 약물 전달체라는 특징이 있으나, 30~50시간 동안 양이온성 물질과 용액 상태의 음이온성 물질을 혼합하여 가교시켜야 하는 큰 단점이 있다.Korean Patent Laid-Open No. 10-2015-00063223 discloses a method of preparing a hydrogel by mixing cationic materials such as chitosan and anionic materials such as carboxymethyl cellulose with electrostatic attraction. Although excellent injectable drug carriers are characterized, there is a big disadvantage of crosslinking by mixing the cationic material and anionic material in a solution state for 30 to 50 hours.
대한민국 공개특허 제10-2014-0016450호는 생체적합성이 우수한 하이드로 겔을 제조하기 위해 사람을 포함하는 동물의 털로부터 추출한 케라틴 유도체를 물에 용해하여 케라틴 유도체 수용액을 제조하고, 여기에 폴리비닐알코올과 폴리에틸렌이민을 첨가 용해하여 혼합물 수용액을 제조한 후, 이 혼합물 수용액에 방사선을 조사하여 가교시켜 상처치료나 피부재생 등에 유용한 하이드로 겔을 제조하는 방법을 개시하였다. 이는 최소한의 화학약품을 사용하여 하이드로 겔을 제조할 수 있기 때문에 친환경적이고 생체적합성이 우수한 장점이 있으나, 방사선 조사에 의해 저분자량의 부산물이 생성되어 쉽게 변색이나 변패가 되기 때문에 상처치료나 피부재생용 하이드로겔로 이용하는 것은 적합하지 않은 문제점이 있다.Korean Patent Publication No. 10-2014-0016450 discloses an aqueous solution of keratin derivatives by dissolving keratin derivatives extracted from the hair of animals including humans in water to prepare hydrogels having excellent biocompatibility. After adding and dissolving polyethyleneimine to prepare a mixture aqueous solution, a method of preparing a hydrogel useful for wound healing or skin regeneration by irradiating the mixture aqueous solution with radiation is disclosed. This has the advantage of being eco-friendly and biocompatible because it can produce hydrogels with minimal chemicals.However, it can be easily discolored or discolored by the production of low-molecular weight by-products for wound treatment or skin regeneration. Use as a hydrogel has an unsuitable problem.
또한, 대한민국 등록특허 제20-0390463호는 부직포에 글리세린, 폴리에틸렌글리콜, 정제수, 폴리아크릴산나트륨, 주석산 및 건조수산화 알루미늄으로 조성되는 하이드로겔을 부직포에 도포하여 상처치료용 밴드를 제조하는 방법을 개시하였으나, 55 내지 68 중량부의 많은 양의 정제수를 함유하고 있기 때문에 흡수도가 낮아져 초기 상처에 나타나는 많은 양의 삼출액을 흡수하는 데에는 한계가 있으며, 과도한 습윤 환경이 조성되어 초기 상처 치유 시간이 길어지는 문제점이 있다. In addition, Korean Patent No. 20-0390463 discloses a method for preparing a wound band by applying a hydrogel composed of glycerin, polyethylene glycol, purified water, sodium polyacrylate, tartaric acid, and dry aluminum hydroxide to a nonwoven fabric. , 55 to 68 parts by weight of a large amount of purified water is low because there is a limit to absorb the large amount of exudates that appear in the initial wound, there is a problem that the excessive wound environment is formed to prolong the initial wound healing time have.
이에, 본 발명자들은 상기 문제점을 해결하기 위하여 예의 노력한 결과, 정제수, 수용성 고분자, 가교제 및 가소제의 함량을 적절히 조절할 경우, 두께가 얇고, 흡수도가 높으며, 점착력이 낮은 상처 치료용 고흡수성 제로겔 드레싱제를 제조할 수 있다는 것을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made diligent efforts to solve the above problems, and when the content of purified water, water-soluble polymer, crosslinking agent and plasticizer is properly adjusted, the thickness of thin, high absorbency, and low adhesion, super absorbent zero gel dressing for wound treatment It was confirmed that the agent can be produced, and the present invention was completed.
본 발명의 목적은 두께가 얇고, 흡수도가 높으며, 점착력이 낮은 제로겔 드레싱제를 제공하는데 있다.SUMMARY OF THE INVENTION An object of the present invention is to provide a zero gel dressing agent having a thin thickness, high water absorption, and low adhesion.
상기 목적을 달성하기 위하여, 본 발명은 (a) 지지체; (b) 상기 지지체의 상부에 적층된 제로겔; (c) 상기 지지체의 하부에 합지된 밀착포; 및 (d) 상기 제로겔에 피복된 이형필름을 포함하는 제로겔 드레싱제에 있어서, 상기 제로겔은 정제수 10~40중량%; 가소제 45~80중량%; 수용성 고분자 8~13중량% 및 가교제 0.01~5중량%를 포함하는 것을 특징으로 하는 제로겔 드레싱제를 제공한다.In order to achieve the above object, the present invention (a) a support; (b) a zero gel stacked on top of the support; (c) an adhesive cloth laminated on the lower portion of the support; And (d) a zero gel dressing agent comprising a release film coated on the zero gel, wherein the zero gel is 10 to 40% by weight of purified water; Plasticizer 45-80 wt%; It provides a zero gel dressing agent comprising 8 to 13% by weight of a water-soluble polymer and 0.01 to 5% by weight of a crosslinking agent.
본 발명에 있어서, 상기 가소제는 글리세린, 1,3-부틸렌글리콜, 프로필렌글리콜, 솔비톨, 디프로필렌글리콜, 에틸렌글리콜 및 폴리에틸렌글리콜로 구성된 군으로부터 선택되는 1종 이상인 것을 특징으로 한다.In the present invention, the plasticizer is at least one member selected from the group consisting of glycerin, 1,3-butylene glycol, propylene glycol, sorbitol, dipropylene glycol, ethylene glycol and polyethylene glycol.
본 발명에 있어서, 상기 수용성 고분자는 천연 고분자, 합성 고분자 및 반합성 고분자로 구성된 군으로부터 선택되는 1종 이상인 것을 특징으로 한다.In the present invention, the water-soluble polymer is characterized in that at least one member selected from the group consisting of natural polymers, synthetic polymers and semi-synthetic polymers.
본 발명에 있어서, 상기 가교제는 수산화알루미늄, 알루미늄마그네슘실리케이트, 알루미늄글리시네이트, 염화알루미늄 및 황산알루미늄으로 구성된 군으로부터 선택되는 1종 이상인 것을 특징으로 한다.In the present invention, the crosslinking agent is at least one member selected from the group consisting of aluminum hydroxide, aluminum magnesium silicate, aluminum glycinate, aluminum chloride and aluminum sulfate.
본 발명에 있어서, 상기 제로겔의 두께는 100~300㎛이며, 하기 측정법에 따른 상기 제로겔의 점착력은 쇠구슬의 호수가 5호(직경: 9.5mm, 중량: 3.5g) 미만이고, 흡수도는 400% 이상인 것을 특징으로 한다.In the present invention, the thickness of the zero gel is 100 ~ 300㎛, the adhesive strength of the zero gel according to the measurement method is less than No. 5 (diameter: 9.5mm, weight: 3.5g) of the iron beads, the absorbency is It is characterized by more than 400%.
<점착력 측정><Measurement of adhesion force>
제로겔을 10㎝×10㎝의 크기로 절단하여 경사각 30°, 경사면의 길이 30㎝의 점착력시험기를 사용하여 경사면 위에 검체의 점착면을 위로 향하게 놓고 경사면의 상단 10㎝, 하단15㎝ 이하에 종이를 붙인 후, 쇠구슬의 호수에 따라 경사면의 상부 끝단에서 굴렸을 때 정지하는 구슬의 호수를 측정함Zero-gel is cut into 10cm × 10cm size and the sample adhesive face up on the inclined surface by using the adhesion tester with the inclination angle of 30 ° and the length of 30cm on the inclined surface. Measure the lake of the bead when it rolls from the upper end of the slope along the lake of the iron ball.
Figure PCTKR2015011600-appb-I000001
Figure PCTKR2015011600-appb-I000001
<흡수도 측정><Absorbance measurement>
제로겔을 5㎝×5㎝의 크기로 절단하여 1시간 동안 25℃ 생리식염수(0.9%의 염화나트륨수용액)에 침적시킨 후, 꺼내어 10분간 상온에서 건조시키고, 무게 변화량을 측정하여 다음 식으로 계산함The gel was cut into 5cm × 5cm size and immersed in 25 ℃ physiological saline solution (0.9% sodium chloride solution) for 1 hour, then taken out and dried at room temperature for 10 minutes, and the weight change was measured and calculated by the following equation.
흡수도(%) = (침적 후의 무게-침적 전의 무게) / 침적 전의 무게 × 100Absorption (%) = (Weight after deposition-Weight before deposition) / Weight before deposition × 100
본 발명에 따른 드레싱제의 제로겔은 3차원 그물망 구조의 가교 결합체로서 수분함량이 낮아 삼출액의 흡수기능이 향상되고, 상처치료 효과가 매우 빠르며, 점착력이 매우 낮고, 두께가 얇기 때문에 상처에 달라붙지 않아 떼어낼 때 통증이 거의 없고, 잔유물이 남지 않으며, 다량의 가소제 의해 보습환경을 만들어 주기 때문에 상처부위가 매끄럽게 치료되며, 또한 딱지가 생기지 않아 치료 후에 흉터가 거의 나타나지 않는 효과가 있다.The zero gel of the dressing agent according to the present invention is a cross-linked body of a three-dimensional network structure, which has a low water content, thereby improving the absorption function of the effusion solution, the wound healing effect is very fast, the adhesive strength is very low, and the thickness is small so that it does not stick to the wound. When you remove it, there is little pain, no residue is left, and a large amount of plasticizer creates a moisturizing environment, so the wound is smoothly treated, and there is no scab, so there is almost no scar after treatment.
도 1은 본 발명의 일 실시예에 따라 제조된 제로겔 드레싱제 사진이다. 1 is a photograph of a zero gel dressing agent prepared according to an embodiment of the present invention.
본 발명에서 가소제는 정제수의 함량과 상관관계가 있는 조성으로서, 정제수의 함량이 낮을 경우에는 가소제의 함량을 증량하여야 하는데, 글리세린, 1,3-부틸렌글리콜, 프로필렌글리콜, 솔비톨, 디프로필렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜 중에서 1종 또는 2종 이상을 혼합하여 사용할 수 있으며, 45~80중량%를 사용하는 것이 바람직하다. 상기 가소제의 함량이 45중량% 미만인 경우 유연성이 없고, 80중량%를 초과할 경우에는 점도가 낮아져 매우 끈적거리게 되고, 가교시간이 길어지는 문제점이 있다. In the present invention, the plasticizer is a composition that is correlated with the content of purified water, and when the content of the purified water is low, the content of the plasticizer should be increased, and glycerin, 1,3-butylene glycol, propylene glycol, sorbitol, dipropylene glycol, It can be used 1 type or in mixture of 2 or more types from ethylene glycol and polyethylene glycol, and it is preferable to use 45-80 weight%. When the content of the plasticizer is less than 45% by weight, there is no flexibility, and when the content of the plasticizer exceeds 80% by weight, the viscosity becomes very sticky and the crosslinking time is long.
본 발명에서 수용성 고분자는 3차원 그물망구조의 가교결합체로 조성되는 일 성분으로서 천연 고분자, 합성 고분자 및 반합성 고분자를 사용할 수 있으며, 천연고분자로서 콜라겐, 젤라틴, 잔탄검, 카라기난, 한천, 알긴산 또는 그의 염, 히아루론산 또는 그의 염, 펙틴, 전분 등을 사용할 수 있으며, 합성 고분자로는 폴리아크릴산 또는 그의 염, 폴리비닐알코올, 폴리비닐피롤리돈, 폴리에틸렌옥사이드, 메틸비닐에테르무수말레인산공중합체, 이소부틸렌무수말레인산공중합체, 메타아크릴산아크릴산부틸공중합체, 메톡시에틸렌무수말레인산공중합체 등을 사용할 수 있으며, 반합성 고분자로서 소디움카르복시메틸셀룰로오즈, 가용성 전분, 카르복시메틸전분에서 선택된 1종이상의 성분을 사용할 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the water-soluble polymer may be a natural polymer, a synthetic polymer and a semi-synthetic polymer as one component composed of a cross-linked body of a three-dimensional network structure, and as a natural polymer, collagen, gelatin, xanthan gum, carrageenan, agar, alginic acid or salts thereof , Hyaluronic acid or salts thereof, pectin, starch and the like can be used, and synthetic polymers include polyacrylic acid or salts thereof, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene oxide, methyl vinyl ether maleic anhydride copolymer, isobutylene anhydride Maleic acid copolymer, butyl methacrylate acrylic acid copolymer, methoxy ethylene maleic anhydride copolymer, etc. may be used.As a semi-synthetic polymer, one or more components selected from sodium carboxymethyl cellulose, soluble starch, and carboxymethyl starch may be used. It is not limited.
상기 수용성 고분자의 함량은 8~13중량%를 사용하는 것이 바람직하다. 상기 수용성 고분자의 함량이 8중량% 미만인 경우에는 흡수도가 낮아지거나, 물에 녹는 현상이 나타날 수 있으며, 13중량%를 초과할 경우에는 점도가 높아져 배합하기 어려우며, 얇게 도포하기 어려운 문제점이 있다. The content of the water-soluble polymer is preferably 8 to 13% by weight. When the content of the water-soluble polymer is less than 8% by weight, the absorbency may be lowered or may be dissolved in water. When the content of the water-soluble polymer is greater than 13% by weight, the viscosity is high, so that it is difficult to formulate and difficult to apply thinly.
본 발명에서 가교제는 수산화알루미늄, 알루미늄마그네슘실리케이트, 알루미늄글리시네이트, 염화알루미늄, 황산알루미늄 등의 알루미늄 화합물에서 1종 또는 2종 이상을 혼합하여 0.01~5중량% 사용할 수 있다. 상기 가교제의 함량을 벗어날 경우에는 수용성 고분자와 최적의 가교결합을 이루지 못하여서 낮은 점착력과 우수한 겔 강도를 가진 제로겔의 제조가 어려워지는 문제점이 있다.In the present invention, the crosslinking agent may be used in an amount of 0.01 to 5 wt% by mixing one or two or more kinds of aluminum compounds such as aluminum hydroxide, aluminum magnesium silicate, aluminum glycinate, aluminum chloride and aluminum sulfate. When the content of the crosslinking agent is out of the range, there is a problem in that it is difficult to produce a zero gel having low adhesive strength and excellent gel strength because it does not achieve optimal crosslinking with the water-soluble polymer.
본 발명에서 산도 조절제는 가교속도를 조절하는 기능이 있으며, 시트릭산, 락틱산, 타르타릭산, 글리콜산 등의 유기산 및 모노에탄올아민, 디에탄올아민, 트리에탄올아민, 디이소프로판올아민 등의 유기염기를 사용할 수 있으며, 그 함량은 0.01~5중량%인 것이 바람직하다.Acidity regulator in the present invention has a function to control the crosslinking rate, organic acids such as citric acid, lactic acid, tartaric acid, glycolic acid and organic base such as monoethanolamine, diethanolamine, triethanolamine, diisopropanolamine It can be used, the content is preferably 0.01 to 5% by weight.
본 발명에서 반응속도 조절제는 에틸렌디아민테트라아세트산 및 그의 염, 소디움폴리아크릴레이트(분자량: 10,000 이하), 인산염 중의 1종 또는 2종 이상을 혼합 사용할 수 있으며, 그 함량은 0.01~5중량%인 것이 바람직하다. In the present invention, the reaction rate modifier may be used by mixing one or two or more of ethylenediaminetetraacetic acid and salts thereof, sodium polyacrylate (molecular weight: 10,000 or less), phosphate, and the content is 0.01 to 5% by weight. desirable.
본 발명에서 방부제는 메틸파라벤, 프로필파라벤, 페녹시에탄올, 1,2-헥산디올, 1,2-옥탄디올, 클로로페네신 등을 1종 또는 2종 이상을 혼합 사용할 수 있으며, 그 함량은 각 국가의 식품의약품안전처에서 고시한 함량을 기준으로 사용하는 것이 바람직하다.In the present invention, preservatives may be used one or two or more of methylparaben, propylparaben, phenoxyethanol, 1,2-hexanediol, 1,2-octanediol, chlorophenesin, etc., the content of each It is recommended to use it as a standard based on the content announced by the Ministry of Food and Drug Safety.
본 발명에 있어서, 상기 제로겔은 계면활성제, 안정화제, 용해보조제, 색소 등을 추가로 함유할 수 있다. 계면활성제는 경피 흡수를 촉진시키고, 조성물들의 안정성을 유지시키기 위한 것으로서, 음이온 계면활성제, 비이온 계면활성제, 양이온 계면활성제, 양성 계면활성제를 사용할 수 있으며, 이들 중에서 1종 또는 2종 이상을 선택하여 혼합사용할 수 있다. In the present invention, the zero gel may further contain a surfactant, stabilizer, dissolution aid, pigment. Surfactants are for promoting transdermal absorption and maintaining the stability of the compositions, anionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants can be used, one or two or more of these Can be used mixed.
또한, 안정화제는 디부틸하이드록시톨루엔, 피로아황산나트륨, 부틸하이드록시아니솔, 아스코르브산 등의 산화방지제를 사용할 수 있으며, 용해보조제는 동식물성 오일 또는 그의 유도체를 선택하여 사용할 수 있다. 색소는 산화티탄, 산화아연, 산화철, 수용성염료, 안료 등을 예시할 수 있으나, 이에 한정되는 것은 아니다.In addition, the stabilizer may be used antioxidants such as dibutyl hydroxy toluene, sodium pyrosulfite, butyl hydroxy anisole, ascorbic acid, the dissolution aid may be selected from animal and vegetable oils or derivatives thereof. The dye may be exemplified by titanium oxide, zinc oxide, iron oxide, water-soluble dyes, pigments, etc., but is not limited thereto.
본 발명의 제로겔은 필요에 따라 상기의 성분 이외에 제로겔의 물리화학적 성질을 변화시키지 않는 범위에서 상처치료 기능이 있는 약용성분, 부형제, 무기충진제, 점도조절제 등의 첨가제를 사용할 수 있다.The zero gel of the present invention may use additives such as medicinal ingredients, excipients, inorganic fillers, viscosity modifiers and the like having a wound healing function in a range that does not change the physical and chemical properties of the zero gel in addition to the above components as necessary.
본 발명에서 밀착포는 제로겔을 피부에 부착시키기 위해 지지체가 중앙에 위치하도록 덧 붙여 사용하는 것으로서, 부직포, 섬유, 면, 레이온, 폴리에틸렌 필름, 폴리우레탄 필름 또는 폴리에틸렌프탈레이트 필름을 1종 또는 2종 이상이 합지된 한 쪽 면에 점착제가 도포된 것을 사용할 수 있으며, 지지체의 크기에 비해 양쪽 길이의 합이 10~50㎜ 크게 되도록 절단하여 사용하는 것이 바람직하다. 양쪽 길이의 합이 10㎜ 미만일 경우 피부에 붙이는 점착면이 좁아 드레싱제가 피부에서 떨어지기 쉬우며, 50㎜를 초과할 경우에는 피부에 붙이는 점착면이 너무 넓어 밀착포가 의류나 외부의 마찰에 의해 쉽게 말리는 현상이 나타나는 문제점이 있다.In the present invention, the adhesive cloth is used by attaching the support to the center to attach the zero gel to the skin, one or two kinds of nonwoven fabric, fiber, cotton, rayon, polyethylene film, polyurethane film or polyethylene phthalate film. It can be used that the adhesive was applied to one surface of the above-mentioned laminated, and it is preferable to cut and use so that the sum of both lengths may become 10-50 mm larger than the magnitude | size of a support body. If the sum of both lengths is less than 10mm, the adhesive surface to be applied to the skin is narrow, so the dressing agent is easy to fall off the skin. If the length exceeds 50mm, the adhesive surface to the skin is too wide, so the adhesive cloth can be easily removed by clothing or external friction. There is a problem in which drying occurs.
본 발명의 제로겔 드레싱제는 상처 부위에 직접 닿는 제로겔 층을 외부 오염으로부터 보호하기 위하여 이형필름 또는 이형지를 포함할 수 있는데, 이형필름은 투명 또는 백색의 불투명한 폴리에틸렌프탈레이트, 폴리에틸렌, 폴리프로필렌, 폴리염화비닐, 폴리카보네이트 소재의 필름을 예시할 수 있고, 이형지는 종이를 폴리에틸렌으로 코팅한 후, 실리콘, 불소 등으로 이형처리시킨 것을 예시할 수 있다.The zero gel dressing agent of the present invention may include a release film or a release paper to protect the zero gel layer directly contacting the wound from external contamination, the release film may be a transparent or white opaque polyethylene phthalate, polyethylene, polypropylene, Examples of the polyvinyl chloride and polycarbonate films may be exemplified, and the release paper may be exemplified by release of silicone, fluorine, or the like after the paper is coated with polyethylene.
이형필름 또는 이형지의 두께는 10~200㎛의 범위에서 선택하여 사용하는 것이 바람직하다. 10㎛ 미만의 것은 너무 얇아서 제로겔의 형태를 유지하기 어렵고 훼손되기 쉬우며, 200㎛를 초과할 경우 너무 두껍기 때문에 취급하기 불편한 문제점이 있다. It is preferable to select and use the thickness of a release film or a release paper in the range of 10-200 micrometers. Less than 10㎛ is too thin to maintain the shape of the zero gel is easy to be damaged, there is a problem that is difficult to handle because it is too thick when it exceeds 200㎛.
본 발명에서 유연성이 우수한 제로겔의 두께(중량환산치)는 100~300㎛가 바람직하다. 100㎛ 미만으로는 지지체에 적층하기 어려우며, 흡수도가 낮은 문제점이 나타날 수 있고, 300㎛를 초과하여 적층할 경우에는 사용감 품질이 나쁘게 된다. In the present invention, the thickness (weight conversion) of the zero gel having excellent flexibility is preferably 100 to 300 µm. If the thickness is less than 100 µm, it may be difficult to stack on the support, and the problem may be low in absorbency.
본 발명에 있어서, 상기 제로겔의 점착력은 쇠구슬의 호수가 5호(직경: 9.5mm, 중량: 3.5g) 미만인 것을 특징으로 한다.In the present invention, the adhesive force of the zero gel is characterized in that the lake of iron ball is less than 5 (diameter: 9.5mm, weight: 3.5g).
제로겔의 점착력은 드레싱 교체 시 통증이나 2차 외상을 일으키지 않고 상처를 안전하게 치료할 수 있는 요소로서, 초기 점착력을 측정할 수 있다.The adhesive strength of zero gel is an element that can safely treat a wound without causing pain or secondary trauma during dressing change, and can measure initial adhesive force.
즉, 본 발명에서 제로겔의 점착력 측정은 제로겔을 10㎝×10㎝의 크기로 절단하여 경사각 30°, 경사면의 길이 30㎝의 점착력시험기를 사용하여 경사면 위에 검체의 점착면을 위로 향하게 놓고 경사면의 상단 10㎝, 하단 15㎝ 이하에 종이를 붙인 후, 하기 표 1의 쇠구슬의 호수에 따라 경사면의 상부 끝단에서 굴렸을 때 정지하는 구슬의 호수를 측정할 수 있다.That is, in the present invention, the adhesive strength of the zero gel is measured by cutting the zero gel into a size of 10 cm × 10 cm and using the adhesion tester having an inclination angle of 30 ° and an inclination surface length of 30 cm. After pasting the paper on the upper 10cm, the lower 15cm or less of the, can be measured by the lake of the marble to stop when rolled from the upper end of the slope according to the lake of the iron ball of Table 1 below.
표 1
호 수 1 2 3 4 5 6 7 8 9
직경 3.2 4.8 6.3 7.9 9.5 11.1 12.7 14.3 15.9
inch 1/8 3/16 1/4 5/16 3/8 7/16 1/2 9/16 5/8
중량 g 0.13 0.45 1.00 2.00 3.50 5.60 8.30 11.90 16.30
Table 1
Lake One 2 3 4 5 6 7 8 9
diameter Mm 3.2 4.8 6.3 7.9 9.5 11.1 12.7 14.3 15.9
inch 1/8 3/16 1/4 5/16 3/8 7/16 1/2 9/16 5/8
weight g 0.13 0.45 1.00 2.00 3.50 5.60 8.30 11.90 16.30
참고로 쇠구슬의 호수가 5호 이상인 높은 점착력은 드레싱 교체 시 통증이나 2차 외상을 일으킬 수 있다.For reference, the high cohesion of the lake of iron ball 5 or more can cause pain or secondary trauma during dressing change.
또한, 상기 제로겔의 흡수도는 상처치료 기능을 가지는 삼출액의 흡수능을 나타내는 척도로서, 흡수도가 높을수록 상처 치유능이 우수하며, 400% 이상인 것이 바람직하다. 400% 미만일 경우에는 삼출물이 많이 생성되는 초기 상처 치료가 지연될 수 있다.In addition, the absorbency of the zero gel is a measure of the absorption ability of the exudate having a wound healing function, the higher the absorption, the better the wound healing ability, preferably 400% or more. If it is less than 400%, initial wound treatment may be delayed, which produces a large amount of exudate.
본 발명에서 제로겔의 흡수도는 제로겔을 5㎝×5㎝의 크기로 절단하여 1시간 동안 25℃ 생리식염수(0.9%의 염화나트륨수용액)에 침적시킨 후, 꺼내어 10분간 상온에서 건조시키고, 무게 변화량을 측정하여 다음 식으로 계산할 수 있다.Absorbance of the zero gel in the present invention is cut to a size of 5cm × 5cm zero gel immersed in 25 ℃ physiological saline (0.9% sodium chloride solution) for 1 hour, then taken out and dried at room temperature for 10 minutes, weighed The amount of change can be measured and calculated by the following equation.
흡수도(%) = (침적 후의 무게-침적 전의 무게) / 침적 전의 무게 × 100Absorption (%) = (Weight after deposition-Weight before deposition) / Weight before deposition × 100
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
실시예Example 1~4 및  1-4 and 비교예Comparative example 1~3:  1 to 3: 제로겔Zero gel 드레싱제 제조 Dressing agent manufacturing
하기 표 2의 조성(단위 중량%)으로, 가소제에 가교제, 반응속도 조절제, 방부제 및 수용성 고분자를 첨가하여 균일하게 분산시킨 후, 산도 조절제를 용해시킨 정제수와 균일하게 혼합하여 겔을 제조하였다. 다음으로 지지체(평균 중량 16g/㎡의 부직포를 20㎛ 두께의 폴리에틸렌 필름)에 겔을 일정한 두께로 도포하고 이형필름(75㎛ 두께의 투명한 폴리에틸렌프탈레이트 필름)을 붙인 후, 건조 숙성하여 제로겔을 제조하여 일정한 크기로 절단함으로써 제로겔 드레싱제를 제조하였다.In the composition (unit weight%) of Table 2, a crosslinking agent, a reaction rate regulator, a preservative, and a water-soluble polymer were added to the plasticizer to be uniformly dispersed, and then uniformly mixed with purified water in which the acidity regulator was dissolved to prepare a gel. Next, a gel was applied to a support (a nonwoven fabric having an average weight of 16 g / m 2, a 20 μm thick polyethylene film) at a constant thickness, a release film (75 μm thick transparent polyethylene phthalate film) was attached, and dried and aged to prepare a zero gel. By cutting to a constant size to prepare a gel preparation.
표 2
구 분 실시예1 실시예2 실시예3 실시예4 비교예1 비교예2 비교예3
폴리아크릴산나트륨 13.00 10.00 10.00 8.00 7.70 13.70 10.00
글리세린 50.00 48.70 45.00 80.00 80.50 44.50 79.20
에틸렌디아민테트라아세트산나트륨 0.30 0.30 0.30 0.50 0.30 0.30 0.30
알루미늄마그네슘실리케이트 0.30 0.30 0.30 0.50 0.30 0.30 0.30
메틸파라벤 0.15 0.15 0.15 0.25 0.15 0.15 0.15
프로필파라벤 0.05 0.05 0.05 0.25 0.05 0.05 0.05
타르타릭산 0.50 0.50 0.50 0.50 0.50 0.50 0.50
정제수 35.70 40.00 33.70 10.00 10.50 40.50 9.50
합 계 100.0 100.0 100.0 100.0 100.0 100.0 100.0
TABLE 2
division Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3
Sodium polyacrylate 13.00 10.00 10.00 8.00 7.70 13.70 10.00
glycerin 50.00 48.70 45.00 80.00 80.50 44.50 79.20
Sodium Ethylenediaminetetraacetic Acid 0.30 0.30 0.30 0.50 0.30 0.30 0.30
Aluminum Magnesium Silicate 0.30 0.30 0.30 0.50 0.30 0.30 0.30
Methylparaben 0.15 0.15 0.15 0.25 0.15 0.15 0.15
Propylparaben 0.05 0.05 0.05 0.25 0.05 0.05 0.05
Tartaric acid 0.50 0.50 0.50 0.50 0.50 0.50 0.50
Purified water 35.70 40.00 33.70 10.00 10.50 40.50 9.50
Sum 100.0 100.0 100.0 100.0 100.0 100.0 100.0
실험예Experimental Example 1: 품질평가 1: quality evaluation
실시예 1~4 및 비교예 1~3의 조성물에 대하여 다음과 같이 배합시 균일성, 첩부 시 피부 잔유물, 흡수도, 점착력 및 두께를 측정하였다. For the compositions of Examples 1 to 4 and Comparative Examples 1 to 3, the uniformity at the time of blending, the skin residue at the time of sticking, the absorbency, the adhesion and the thickness were measured.
1-1: 배합시 균일성(혼합도)1-1: Uniformity in Mixing (Mixed Degree)
본 발명의 제로겔은 시간 경과에 따라 점도가 상승하는 특성을 가지고 있어 점도계를 사용하여 점도를 정확히 측정하는 데에 한계가 있기 때문에 배합 시 균일성을 육안으로 관찰하여 비교하고, 그 결과를 표 3에 나타내었다. Since the zero gel of the present invention has a characteristic that the viscosity increases with time, and there is a limit in accurately measuring the viscosity using a viscometer, the uniformity at the time of blending is observed and compared, and the results are shown in Table 3 below. Shown in
표 3
구 분 실시예1 실시예2 실시예3 실시예4 비교예1 비교예2 비교예3
균일성 X X
TABLE 3
division Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3
Uniformity X X
◎: 매우 좋음 ○: 좋음 X: 유동성이 없으며, 불균일함◎: Very good ○: Good X: No fluidity, nonuniform
1-2: 1-2: 첩부Affix 시 피부  City skin 잔유물Remnants
실시예 1~4 및 비교예 1~3에서 제조된 제로겔 드레싱제를 5㎝ × 5㎝의 크기로 절단하여 10명의 피시험자를 대상으로 6시간 동안 피부에 첩포한 후, 잔유물 및 끈적임 상태를 5점 척도로 분석하고, 그 결과를 표 4에 나타내었다.The zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 5 cm × 5 cm and patched to the skin of 10 subjects for 6 hours, and then the residue and stickiness were examined. The analysis was carried out on a 5-point scale, and the results are shown in Table 4.
표 4
구 분 실시예1 실시예2 실시예3 실시예4 비교예1 비교예2 비교예3
잔유물 5.0 5.0 5.0 4.8 1.5 4.5 4.0
Table 4
division Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3
Remnants 5.0 5.0 5.0 4.8 1.5 4.5 4.0
5점: 잔유물이 없음. 4점: 잔유물 및 끈적임이 거의 없음. 3점: 잔유물이 없으나, 약간 끈적임. 2점: 잔유물이 약간 있음. 1점: 잔유물이 피부에 남음5 points | pieces: There is no residue. 4 points | pieces: There is little residue and stickiness. 3 points | pieces: There is no residue but is a little sticky. 2 points | pieces: There is a little residue. 1 point: Remnants remain on the skin
1-3: 흡수도 측정1-3: Absorbance Measurement
실시예 1~4 및 비교예 1~3에서 제조된 제로겔 드레싱제를 5㎝ × 5㎝의 크기로 절단하여 1시간 동안 25℃ 생리식염수(0.9%의 염화나트륨수용액)에 침적시킨 후, 꺼내어 10분간 상온에서 건조시키고, 무게 변화량을 측정하여 다음 식으로 계산한 다음, 그 결과를 표 5에 나타내었다.The zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 5 cm × 5 cm, immersed in 25 ° C. saline (0.9% sodium chloride solution) for 1 hour, and then taken out. After drying at room temperature for minutes, the weight change was measured and calculated by the following equation, and the results are shown in Table 5.
흡수도(%) = (침적 후의 무게-침적 전의 무게) / 침적 전의 무게 × 100  Absorption (%) = (Weight after deposition-Weight before deposition) / Weight before deposition × 100
표 5
구 분 실시예1 실시예2 실시예3 실시예4 비교예1 비교예2 비교예3
흡수도(%) 524.6 501.2 460.5 429.7 흘러내림 280.5 605.2
Table 5
division Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3
Absorbance (%) 524.6 501.2 460.5 429.7 Dripping 280.5 605.2
1-4: 점착력 측정1-4: adhesive force measurement
실시예 1~4 및 비교예 1~3에서 제조된 제로겔 드레싱제를 10㎝ × 10㎝의 크기로 절단하여 경사각 30° 경사면의 길이 30㎝의 점착력 시험기를 사용하여 경사면 위에 검체의 점착면을 위로 향하게 놓고 경사면의 상단 10㎝, 하단15㎝ 이하에 종이를 붙인 후, 쇠구슬의 호수에 따라 경사면의 상부 끝단에서 굴렸을 때 정지하는 구슬의 호수를 측정하고, 그 결과를 표 6에 나타내었다. 참고로 쇠구슬의 호수별 직경 및 중량은 표 7에 나타내었다.The zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 10 cm × 10 cm, and the adhesive surface of the specimen was placed on the inclined surface using an adhesion tester having a 30 cm length of inclined angle of 30 °. Place the paper on the top 10cm and the bottom 15cm of the inclined surface facing up, and measure the lake of the marble which stops when rolling at the upper end of the slope according to the lake of the iron ball, the results are shown in Table 6. . For reference, the diameter and weight of the steel ball by lake are shown in Table 7.
표 6
구 분 실시예1 실시예2 실시예3 실시예4 비교예1 비교예2 비교예3
점착력 1 1 1 3 7 5 6
Table 6
division Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3
adhesiveness One One One 3 7 5 6
표 7
호 수 1 2 3 4 5 6 7 8 9
직경 3.2 4.8 6.3 7.9 9.5 11.1 12.7 14.3 15.9
inch 1/8 3/16 1/4 5/16 3/8 7/16 1/2 9/16 5/8
중량 g 0.13 0.45 1.00 2.00 3.50 5.60 8.30 11.90 16.30
TABLE 7
Lake One 2 3 4 5 6 7 8 9
diameter Mm 3.2 4.8 6.3 7.9 9.5 11.1 12.7 14.3 15.9
inch 1/8 3/16 1/4 5/16 3/8 7/16 1/2 9/16 5/8
weight g 0.13 0.45 1.00 2.00 3.50 5.60 8.30 11.90 16.30
1-5: 두께(중량환산) 측정1-5: Thickness (weight conversion) measurement
실시예 1~4 및 비교예 1~3에서 제조된 제로겔 드레싱제를 10㎝ × 10㎝의 크기로 절단하여 각 시료의 무게를 정확히 측정하고, 이형필름 및 지지체의 무게를 제외한 제로겔 자체 무게를 계산하였다. 무게가 1g일 때 제로겔의 두께는 100㎛와 동일한 것으로 환산하고, 그 결과를 표 8에 나타내었다.The zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 were cut to a size of 10 cm × 10 cm to accurately measure the weight of each sample, and the weight of the zero gel itself except the weight of the release film and the support. Was calculated. When the weight is 1g, the thickness of the zero gel is converted to the same as 100 μm, and the results are shown in Table 8.
표 8
구 분 실시예1 실시예2 실시예3 실시예4 비교예1 비교예2 비교예3
점착력 208㎛ 222㎛ 220㎛ 187㎛ 184㎛ 210㎛ 318㎛
Table 8
division Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Comparative Example 2 Comparative Example 3
adhesiveness 208 ㎛ 222 ㎛ 220 ㎛ 187 ㎛ 184 ㎛ 210 μm 318 ㎛
이상의 품질평가 결과, 배합시 균일성에서 정제수의 함량이 낮은 비교예 3을 제외한 실시예 1 내지 실시예 4, 비교예 1 및 비교예 2는 우수하게 나타났고, 가소제의 함량이 높은 비교예 1은 끈적이고 잔유물이 피부에 남으며, 흡수도 측정 시 식염수를 흡수한 겔이 녹아서 흘러내리는 현상이 심하게 나타났다. As a result of the above quality evaluation, Examples 1 to 4, Comparative Example 1 and Comparative Example 2 were excellent except for Comparative Example 3 in which the content of the purified water in the uniformity was low, and Comparative Example 1 having a high plasticizer content was Sticky and residues remained on the skin, and when absorbance was measured, the gel absorbing saline melted and ran down.
또한 정제수 함량이 높은 비교예 2는 상대적으로 흡수도가 낮게 나타났다. 비교예 3은 흡수도가 높게 나타났는데, 이는 정제수의 함량이 낮고, 두껍게 도포되어 나타난 현상으로 판단된다. In addition, Comparative Example 2 having a high purified water content showed a relatively low water absorption. Comparative Example 3 showed a high water absorption, which is considered to be a phenomenon in which the content of purified water was low and appeared to be thickly applied.
한편, 비교예 3은 피부 부착 시 잔유물이 없으나, 두께에 대한 이질감 때문에 사용감이 나쁘다는 의견이 많았다. On the other hand, Comparative Example 3, there is no residue when the skin attached, there were many opinions that the feeling of use is bad because of the heterogeneity to the thickness.
점착력 측정결과에서 비교예 1 내지 비교예 3은 점착력이 높은 것으로 나타나 상처에 붙였다 떼어낼 때 통증과 2차 외상을 유발할 수 있을 것으로 추정된다. In the results of the adhesion measurement, Comparative Examples 1 to 3 were found to have high adhesion, which may cause pain and secondary trauma when attached to the wound.
실험예Experimental Example 2: 상처  2: wound 치료능Therapeutic ability 평가 evaluation
실시예 1~4 및 비교예 1~3에서 제조된 제로겔 드레싱제의 상처 치료능은 3월령의 마이크로 피그를 대상으로 30일간 평가하였다. 사육환경으로 온도 24±2℃, 상대습도 50±10%, 환기회수 10~15회(헤파필터), 명암주기 12시간/일, 조도 200룩스, 소음 45db 및 암모니아 20ppm 이하로 관리하였다. No.11 및 No.12의 외과용 매스를 사용하여 마이크로 피그의 등 부위에 3㎝×3㎝의 크기로 피부 전층을 잘라내고, 대조군으로 I사의 폴리우레탄폼으로 제조한 M과 실시예 1에서 제조한 조성물을 5㎝×5㎝의 크기로 절단하여 3개씩 각각의 상처 부위에 붙이고, 그 위에 7㎝×7㎝ 크기의 밀착포를 붙여 떼어지지 않도록 하였다.The wound healing ability of the zero gel dressing agents prepared in Examples 1 to 4 and Comparative Examples 1 to 3 was evaluated for 30 days in the micro pigs of 3 months of age. As a breeding environment, temperature 24 ± 2 ℃, relative humidity 50 ± 10%, ventilation frequency 10 ~ 15 times (Hepa filter), contrast cycle 12 hours / day, roughness 200 lux, noise 45db and ammonia 20ppm were managed. Using the surgical mass of No. 11 and No. 12, the entire skin layer was cut out on the back of the micro pig in the size of 3 cm × 3 cm, and in M and Example 1, which were made of polyurethane foam of Company I as a control. The prepared composition was cut to a size of 5 cm x 5 cm and attached to each wound site three by three, and a 7 cm x 7 cm adhesive cloth was attached thereon so as not to be peeled off.
대조군과 실시예 1에서 제조한 조성물은 3일마다 교환하였으며, 상처 치료 능은 상처의 크기 변화를 PET 필름으로 스캔하고, 면적 프로그램으로 상처의 면적을 측정한 후, 다음 식으로 계산하였으며, 그 결과는 표 9에 나타내었다.The composition prepared in Example 1 and the control group were exchanged every 3 days, and the wound healing ability was calculated by the following equation after measuring the size of the wound with a PET film, measuring the area of the wound with an area program, and as a result, Is shown in Table 9.
상처치료효과(%) = (초기 상처의 크기 - 경시 후 상처의 크기) / 초기 상처의 크기 x 100Wound Healing Effect (%) = (Initial Wound Size-Size after Wound) / Initial Wound Size x 100
표 9
경시일 초 기 3일 6일 9일 12일 15일 18일 21일 24일 27일 30일
실시예1 0 34.9 41.2 55.6 66.7 73.6 86.7 96.4 100.0 - -
대조군 0 34.9 40.2 53.3 55.6 62.0 75.0 79.8 90.0 93.6 97.2
Table 9
Time Early 3 days 6 days 9th 12 days 15th 18 days 21st 24 days 27th 30 days
Example 1 0 34.9 41.2 55.6 66.7 73.6 86.7 96.4 100.0 - -
Control 0 34.9 40.2 53.3 55.6 62.0 75.0 79.8 90.0 93.6 97.2
표 9로부터, 상처치료효과에 있어서 대조군은 삼출액이 많이 나오는 상처 초기에는 실시예 1과 유사한 수준으로 나타났으나, 삼출액이 생성되지 않는 9일 후 부터는 상처부위가 건조하고, 상처부위가 매우 거칠었으며, 상처 치료 속도가 현저하게 떨어지는 것을 관찰할 수 있었다. From Table 9, in the wound treatment effect, the control group showed a similar level as in Example 1 at the initial stage of the effusion, but after 9 days of no effusion, the wound was dried and the wound was very rough. The wound healing rate was significantly decreased.
실시예 1은 상처부위가 건조한 상태에서도 상처치료효과가 상대적으로 매우 빠르게 나타났으며, 상처부위에 딱지가 생성되지 않고, 매끈하게 상처가 치료되는 것이 관찰되었다. 이는 삼출액이 없는 건조한 상태에서도 적절한 보습환경을 형성하기 때문에 딱지를 생성시키지 않아 상처부위가 매끄럽게 치료되는 것으로 사료된다. In Example 1, the wound healing effect appeared relatively quickly even when the wound was dry, and no scab was formed on the wound, and the wound was smoothly treated. It does not produce scabs because it creates a proper moisturizing environment even in the dry state without exudates.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As described above in detail specific parts of the present invention, it will be apparent to those skilled in the art that these specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. will be. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
본 발명에 따른 제로겔 드레싱제는 상처에 달라붙지 않아 떼어낼 때 통증이 거의 없고, 잔유물이 남지 않으며, 다량의 가소제 의해 보습환경을 만들어 주기 때문에 상처부위가 매끄럽게 치료되며, 또한 딱지가 생기지 않아 치료 후에 흉터가 거의 나타나지 않는 효과가 있으므로, 드레싱제로 널리 이용될 수 있다.The zero gel dressing agent according to the present invention does not adhere to the wound, so there is almost no pain when peeling off, no residue is left, and a large amount of plasticizer creates a moisturizing environment, so that the wound is smoothly treated, and no scabs are formed to treat it. Since there is an effect that scars hardly appear afterwards, it can be widely used as a dressing agent.

Claims (5)

  1. (a) 지지체; (b) 상기 지지체의 상부에 적층된 제로겔; (c) 상기 지지체의 하부에 합지된 밀착포; 및 (d) 상기 제로겔에 피복된 이형필름을 포함하는 제로겔 드레싱제에 있어서, (a) a support; (b) a zero gel stacked on top of the support; (c) an adhesive cloth laminated on the lower portion of the support; And (d) a zero gel dressing agent comprising a release film coated on the zero gel,
    상기 제로겔은 정제수 10~40중량%; 가소제 45~80중량%; 수용성 고분자 8~13중량%; 가교제 0.01~5중량%를 포함하는 것을 특징으로 하는 제로겔 드레싱제.The zero gel is 10 to 40% by weight of purified water; Plasticizer 45-80 wt%; Water soluble polymer 8-13% by weight; A zero gel dressing agent comprising 0.01 to 5% by weight of a crosslinking agent.
  2. 제1항에 있어서, 상기 가소제는 글리세린, 1,3-부틸렌글리콜, 프로필렌글리콜, 솔비톨, 디프로필렌글리콜, 에틸렌글리콜 및 폴리에틸렌글리콜로 구성된 군으로부터 선택되는 1 이상인 것을 특징으로 하는 제로겔 드레싱제.The zero gel dressing agent of claim 1, wherein the plasticizer is at least one selected from the group consisting of glycerin, 1,3-butylene glycol, propylene glycol, sorbitol, dipropylene glycol, ethylene glycol, and polyethylene glycol.
  3. 제1항에 있어서, 상기 수용성 고분자는 천연 고분자, 합성 고분자 및 반합성 고분자로 구성된 군으로부터 선택되는 1 이상인 것을 특징으로 하는 제로겔 드레싱제.The zero gel dressing agent of claim 1, wherein the water-soluble polymer is at least one selected from the group consisting of natural polymers, synthetic polymers, and semi-synthetic polymers.
  4. 제1항에 있어서, 상기 가교제는 수산화알루미늄, 알루미늄마그네슘실리케이트, 알루미늄글리시네이트, 염화알루미늄 및 황산알루미늄으로 구성된 군으로부터 선택되는 1 이상인 것을 특징으로 하는 제로겔 드레싱제.The zero gel dressing agent of claim 1, wherein the crosslinking agent is at least one selected from the group consisting of aluminum hydroxide, aluminum magnesium silicate, aluminum glycinate, aluminum chloride and aluminum sulfate.
  5. 제1항에 있어서, 상기 제로겔의 두께는 100~300㎛이며, 하기 측정법에 따른 상기 제로겔의 점착력은 쇠구슬의 호수가 5호(직경: 9.5mm, 중량: 3.5g) 미만이고, 흡수도는 400% 이상인 것을 특징으로 하는 제로겔 드레싱제.According to claim 1, wherein the thickness of the zero gel is 100 ~ 300㎛, the adhesive strength of the zero gel according to the measurement method is less than No. 5 (diameter: 9.5mm, weight: 3.5g) of the iron ball, the absorbency The zero gel dressing agent, characterized in that more than 400%.
    <점착력 측정><Measurement of adhesion force>
    제로겔을 10㎝×10㎝의 크기로 절단하여 경사각 30°, 경사면의 길이 30㎝의 점착력시험기를 사용하여 경사면 위에 검체의 점착면을 위로 향하게 놓고 경사면의 상단 10㎝, 하단 15㎝ 이하에 종이를 붙인 후, 쇠구슬의 호수에 따라 경사면의 상부 끝단에서 굴렸을 때 정지하는 구슬의 호수를 측정함Zero-gel is cut into 10cm × 10cm size, and the adhesive surface of the sample is placed on the inclined surface by using the adhesion tester with an inclination angle of 30 ° and the length of 30cm on the inclined surface. Measure the lake of the bead when it rolls from the upper end of the slope along the lake of the iron ball.
    Figure PCTKR2015011600-appb-I000002
    Figure PCTKR2015011600-appb-I000002
    <흡수도 측정><Absorbance measurement>
    제로겔을 5㎝×5㎝의 크기로 절단하여 1시간 동안 25℃ 생리식염수(0.9%의 염화나트륨수용액)에 침적시킨 후, 꺼내어 10분간 상온에서 건조시키고, 무게 변화량을 측정하여 다음 식으로 계산함The gel was cut into 5cm × 5cm size and immersed in 25 ℃ physiological saline solution (0.9% sodium chloride solution) for 1 hour, then taken out and dried at room temperature for 10 minutes, and the weight change was measured and calculated by the following equation.
    흡수도(%) = (침적 후의 무게-침적 전의 무게)/침적 전의 무게×100Absorbance (%) = (Weight after deposition-Weight before deposition) / Weight before deposition × 100
PCT/KR2015/011600 2015-10-30 2015-10-30 Super absorbent zero gel dressing for treating wound WO2017073826A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150152261 2015-10-30
KR10-2015-0152261 2015-10-30

Publications (1)

Publication Number Publication Date
WO2017073826A1 true WO2017073826A1 (en) 2017-05-04

Family

ID=58630317

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/011600 WO2017073826A1 (en) 2015-10-30 2015-10-30 Super absorbent zero gel dressing for treating wound

Country Status (1)

Country Link
WO (1) WO2017073826A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286737A (en) * 2022-10-08 2022-11-04 科曼尼(吉林)生物科技有限公司 Healing promoting gel precursor, preparation thereof, wound surface gel based on healing promoting gel precursor and preparation thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970004589B1 (en) * 1994-03-04 1997-03-29 주식회사 태평양 Adhesive sheets
KR20030093615A (en) * 2002-06-04 2003-12-11 한웅코텍 주식회사 Hydrophilic gel sheet
KR20050013217A (en) * 2002-06-19 2005-02-03 쇼와 덴코 가부시키가이샤 Hydrous gel and production process and use of the hydrous gel
KR100719433B1 (en) * 2005-11-25 2007-05-17 주식회사 원바이오젠 The method for manufacturing and apparatus of adhesive hydrophilic polyurethane film dressing
KR20080018360A (en) * 2006-08-24 2008-02-28 대화제약 주식회사 A wound-healing dressing patch with hydrogel layer containing chitosan

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970004589B1 (en) * 1994-03-04 1997-03-29 주식회사 태평양 Adhesive sheets
KR20030093615A (en) * 2002-06-04 2003-12-11 한웅코텍 주식회사 Hydrophilic gel sheet
KR20050013217A (en) * 2002-06-19 2005-02-03 쇼와 덴코 가부시키가이샤 Hydrous gel and production process and use of the hydrous gel
KR100719433B1 (en) * 2005-11-25 2007-05-17 주식회사 원바이오젠 The method for manufacturing and apparatus of adhesive hydrophilic polyurethane film dressing
KR20080018360A (en) * 2006-08-24 2008-02-28 대화제약 주식회사 A wound-healing dressing patch with hydrogel layer containing chitosan

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286737A (en) * 2022-10-08 2022-11-04 科曼尼(吉林)生物科技有限公司 Healing promoting gel precursor, preparation thereof, wound surface gel based on healing promoting gel precursor and preparation thereof
CN115286737B (en) * 2022-10-08 2023-01-24 科曼尼(吉林)生物科技有限公司 Healing promoting gel precursor, preparation thereof, wound surface gel based on healing promoting gel precursor and preparation thereof

Similar Documents

Publication Publication Date Title
KR100847971B1 (en) A wound-healing dressing patch with hydrogel layer containing chitosan
CA1245158A (en) Synthetic resin wound dressing and method of treatment using same
EP1123104B1 (en) Inherently antimicrobial quaternary amine hydrogel wound dressings
RU2276998C2 (en) Hydrogel compositions
RU2332238C2 (en) Composition for pads, wound dressing and other articles contacting skin
KR100859339B1 (en) Silicon composition for dressing, the dressing and the method for manufacturing it
KR20010072163A (en) Disposable absorbent articles with improved adhesive for skin attachment
JP2015502430A (en) Buffer adhesive composition for skin adhesive medical products and method for producing the composition
KR20070048229A (en) Adhesive composition
CN105797202B (en) Liquid band-aid and preparation method thereof
JP5878870B2 (en) How to use wound hydrogel sheet
JP6716841B2 (en) Hemostatic material
CN105012960A (en) Film-forming gel composition, application and wound protecting material
WO1994017840A1 (en) Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
KR100542875B1 (en) Hydrogel dressings for wound dressings or packs and its preparation
WO2017073826A1 (en) Super absorbent zero gel dressing for treating wound
KR20110027434A (en) Composition for forming water-repellent film with sustained drug release ability
KR100459494B1 (en) Method for the preparation of hydrogels for wound dressings
KR101775072B1 (en) Silicon mask pack compositoin for moisturizing skin and moisturizing skin and supply nutritional and silicon mask pack using the same
EP0745392A1 (en) Wound covering material
JPS61187866A (en) Novel medical cover material
EP1243260B1 (en) Cicatrizant hydrocolloidal patch containing hyaluronic acid and chondroitin sulphate
Khokhlenkova Prospects of using biopolymeric films in medicine and pharmacy
KR101651574B1 (en) Hydrocolloid containing active ingredient
WO2024090820A1 (en) Gel composition for covering wound and method for manufacturing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15907371

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15907371

Country of ref document: EP

Kind code of ref document: A1